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ABSTRACT Adenoviruses (AdVs) are DNA viruses that infect many vertebrate hosts, including humans and nonhuman primates.
Here we identify a novel AdV species, provisionally named “simian adenovirus C (SAdV-C),” associated with a 1997 outbreak of
acute respiratory illness in captive baboons (4 of 9) at a primate research facility in Texas. None of the six AdVs recovered from
baboons (BaAdVs) during the outbreak, including the two baboons who died from pneumonia, were typeable. Since clinical
samples from the two fatal cases were not available, whole-genome sequencing of nasal isolates from one sick baboon and three
asymptomatic baboons during the outbreak was performed. Three AdVs were members of species SAdV-C (BaAdV-2 and
BaAdV-4 were genetically identical, and BaAdV-3), while one (BaAdV-1) was a member of the recently described SAdV-B spe-
cies. BaAdV-3 was the only AdV among the 4 isolated from a sick baboon, and thus was deemed to be the cause of the outbreak.
Significant divergence (<58% amino acid identity) was found in one of the fiber proteins of BaAdV-3 relative to BaAdV-2 and -4,
suggesting that BaAdV-3 may be a rare SAdV-C recombinant. Neutralizing antibodies to the other 3 AdVs, but not BaAdV-3,
were detected in healthy baboons from 1996 to 2003 and staff personnel from 1997. These results implicate a novel adenovirus
species (SAdV-C) in an acute respiratory outbreak in a baboon colony and underscore the potential for cross-species transmis-
sion of AdVs between humans and nonhuman primates.
IMPORTANCE Adenoviruses (AdVs) are DNA viruses that infect many animals, including humans and monkeys. In 1997, an out-
break of acute respiratory illness from AdVs occurred in a baboon colony in Texas. Here we use whole-genome sequencing and
antibody testing to investigate new AdVs in baboons (BaAdVs) during the outbreak, one of which, BaAdV-3, came from a sick
animal. By sequence analysis, BaAdV-3 may be a recombinant strain that arose from a related BaAdV found in baboons nearby
in the colony (who were not sick) and yet another unknown AdV. We also found antibodies to these new BaAdVs in baboons and
staff personnel at the facility. Taken together, our findings of a new AdV species as the cause of an acute respiratory outbreak in a
baboon colony underscore the ongoing threat from emerging viruses that may carry the potential for cross-species transmission
between monkeys and humans.
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Many emerging infectious diseases in humans, including thosecaused by Ebola virus and H5N1 avian influenza, are zoo-
notic (1). Given the close phylogenetic relationship between hu-
mans and nonhuman primates (NHPs), humans are especially
vulnerable to cross-species infections from pathogens harbored in
apes and monkeys (2). The risk of disease transfer between NHPs
and humans may be greatest in hot spots such as the forests of
central and west Africa and the Amazon basin, where humans
come into frequent contact with a diverse range of closely related
species of NHPs (2). Zoos and research facilities housing captive
NHPs also represent settings in which cross-species transmission
of emerging pathogens can occur (3–5).
Adenoviruses (AdVs), first isolated from human adenoidal tis-
sue (6), are double-stranded DNA viruses that naturally infect a
broad range of vertebrate hosts, including humans and NHPs (7–
9). In humans, infections caused by AdVs include conjunctivitis,
gastroenteritis, hepatitis, myocarditis, and pneumonia (7, 10–16).
Members of the genus Mastadenovirus, which encompass the
AdVs infecting primates, have been classified by the International
Committee on Taxonomy of Viruses (ICTV) to include the 7 hu-
man adenovirus (HAdV) species (HAdV-A to HAdV-G) and 1
simian AdV species (simian adenovirus A [SAdV-A]) (17). Re-
cently, members of a phylogenetically distinct AdV species,
SAdV-B, were also discovered in fecal samples from asymptom-
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atic captive rhesus monkeys (18). Although AdVs are convention-
ally thought to exhibit a very narrow host range due to coevolu-
tion with their respective hosts (7, 17), there is mounting evidence
supporting the potential for cross-species transmission of AdVs
between monkeys and humans. AdVs identified in fecal samples
from NHPs were found to share a remarkable similarity to human
strains and could be classified phylogenetically into the conven-
tional “human” species HAdV-A to HAdV-E (19, 20). Large-scale
serological surveys have detected antibodies to simian AdVs in
humans living in monkey-endemic regions (21, 22). Furthermore,
we previously described a novel AdV, titi monkey adenovirus
(TMAdV), as the cause of a fatal outbreak of pneumonia and
hepatitis in a colony of New World titi monkeys, which was also
associated with a cross-species respiratory infection in a scientist
investigating the outbreak and a household family member (3).
In 1997, an outbreak of fatal pneumonia occurred in infant
olive baboons (Papio hamadryas anubis) housed at the Texas Bio-
medical Research Institute (TBRI). Here we investigate the cause
of the outbreak and identify by sequencing and de novo genome
assembly the presence of a novel AdV species, provisionally
named “simian adenovirus C (SAdV-C),” in both sick and asymp-
tomatic baboons. In addition, we present clinical, epidemiologi-
cal, and serological evidence that members of species SAdV-C and
SAdV-B have the capacity to cause cross-species infections in hu-
mans and monkeys.
RESULTS
A 1997 outbreak of fatal pneumonia in a
baboon colony. In February of 1997, 4 of
9 infant baboons at the TBRI developed
an acute respiratory infection of un-
known etiology shortly after being iso-
lated from birth in preparation for a re-
search study on respiratory syncytial virus
(Fig. 1). The first two cases (Fig. 1, baboon
1 [B1] and B2) died 13 and 5 days after the
onset of symptoms despite treatment
with empiric broad-spectrum antibiotics
and supportive care. Symptoms began
with sneezing and rapidly worsened with
development of lethargy, 20% weight
loss, abnormally low body temperature,
and dyspnea. White blood cell (WBC)
counts were normal, but a few atypical
lymphocytes were present. Chest radio-
graphs revealed a bilateral interstitial
pneumonia. Initial bacterial cultures of
bronchoalveolar lavage fluid and blood
samples were positive for methicillin-
sensitive Staphylococcus aureus (MSSA)
and rare Kluyvera ascorbata (23) in only
one of the two cases.
On necropsy immediately after death,
the lung tissue from both cases was noted
to be hemorrhagic with patchy regions of
consolidation and significant neutro-
philic infiltration. Notably, intranuclear
inclusions (presumably from AdV infec-
tion) were evident throughout the respi-
ratory epithelium and were most evident
in the major airways. The final patholog-
ical diagnosis was bronchointerstitial pneumonia, probably viral
in etiology, with accompanying tonsillitis, lymphadenitis, and
mild liver necrosis (in one baboon). Tests from lung tissue were
negative for Bordetella pertussis, Chlamydophila spp., Mycoplasma
spp., Ureaplasma spp. Legionella spp., and hantavirus. Adenovirus
was isolated in cell culture from bronchoalveolar lavage fluid and
lung tissue samples from both fatal cases. The isolates were un-
typeable by virus neutralization testing at an off-site laboratory
using sera reactive to members of species HAdV-A to HAdV-F
and SAdV-A.
Although clinical samples from the two fatal cases were un-
available for further analysis, two other animals in the room were
noted to be sneezing and coughing around the same time cases B1
and B2 presented with fatal pneumonia (Fig. 1, B3 and B5). Ade-
novirus was isolated from a nasal swab collected from one of these
two symptomatic individuals during the 1997 outbreak (Fig. 1,
room 1, BaAdV-3). Nasal swabs were also collected from the sole
remaining asymptomatic baboon in the same room as the symp-
tomatic cases (Fig. 1, room 1, B4) and from asymptomatic ba-
boons in a nearby but separate room (Fig. 1, room 2, B8 and B9).
From these nasal swabs, 3 additional AdV isolates were obtained
(Fig. 1, BaAdV-1, BaAdV-2, and BaAdV-4). The two symptomatic
baboons in room 1, cases B3 and B5, were quarantined and recov-
ered completely within 1 week with supportive care, including
FIG 1 Epidemiological features of the 1997 baboon adenovirus outbreak. Map of the baboon nursery
during the 1997 outbreak with cages situated in two separate rooms, showing the locations of baboons
who died from pneumonia (skeleton), baboons who became clinically ill with respiratory symptoms
but survived (red), and asymptomatic baboons (brown). The novel AdVs genetically characterized in
this study (BaAdV-1 to BaADV-4) were isolated from nasal swabs from both sick (B5) and asymptom-
atic (B4, B8, and B9) baboons.
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intravenous fluids, oxygen administration, and empirical antibi-
otics. None of the 4 baboon AdV isolates was typeable as HAdV
species A to F or SAdV-A by neutralization testing done in 1997.
Cell culture tropism of novel baboon adenoviruses. We at-
tempted to culture the 4 BAdVs isolated from sick and asymptom-
atic baboons during the 1997 outbreak in a variety of human and
monkey cell lines. The majority of cells and cell lines tested re-
sulted in productive infection as determined by the extent of cy-
topathic effect (CPE) (Table 1). All 4 BAdVs grew efficiently in
cells from other Old World monkey species (rhesus, cynomolgus,
and African green monkeys). In 2012, we tested the BaAdVs for
growth in human cell lines; all 4 grew efficiently in the human lung
adenocarcinoma A549 cell line, which is commonly employed in
isolation of human AdVs (24). Notably, unlike the other 3 AdV
strains, BaAdV-3 was also successfully cultured on two additional
human cell lines. No growth was observed in lymphoblastoid
B95a cells from marmosets, which are New World monkeys.
De novo assembly and whole-genome phylogenetic analysis
of novel baboon adenoviruses (BaAdV-1 to BaAdV-4). In 2012,
we sought to further characterize the 4 AdVs isolated from ba-
boons by whole-genome sequencing and phylogenetic analysis.
The sequences of the AdV hexon, DNA polymerase, and fiber were
initially recovered by Sanger sequencing. To sequence the entire
AdV genome, early passaged cultures corresponding to the 4
BaAdV isolates were subjected to next-generation “deep” se-
quencing on an Illumina HiSeq 2000 (Fig. 2). Out of 32.9 to 45.2
million raw reads, from 61.3% to 93.1% of the genome was assem-
bled de novo for each of the 4 AdV strains. Specific PCR and Sanger
sequencing were then used to confirm the de novo assembly and to
fill in the gaps. The genomic assemblies revealed that all 4 baboon
AdV strains retained the major core adenoviral proteins, and sim-
ilar to AdVs in species SAdV-B, -F, and -G, all 4 strains contained
two fiber proteins (16, 25–28).
By pairwise analysis of nucleotide identity (Fig. 3A), BaAdV-1,
the strain isolated from an asymptomatic baboon in the outbreak
room (Fig. 1, room 1, B4), was found to be closely related to a
previously described SAdV-B strain isolated from a stool sample
from a captive rhesus monkey (SAdV-A1335, GenBank accession
number JN880456, 97.8% identity) (18). Strains BaAdV-2 and
BaAdV-4, both isolated from asymptomatic baboons housed
away from the outbreak location in a separate room (Fig. 1, room
2, B8 and B9), were 100% identical to each other, while strain
BaAdV-3, isolated from a symptomatic baboon positioned near
the two baboons who died from adenoviral pneumonia (Fig. 1,
room 1, B5), was 91.2% identical to strains BaAdV-2/-4 (Fig. 3B).
The closest relatives to BaAdV-2/-4 and BaAdV-3 were members
of AdV species F and G (Fig. 3B and 4). Phylogenetic analysis of
the individual hexon, penton base, DNA polymerase, and fiber
proteins and amino acid pairwise identity comparisons revealed
that BaAdV-1 is a member of the SAdV-B species (Fig. 4 and 5A),
while BaAdV-2/-4 and BaAdV-3 appear to be members of a new
species intermediate between SAdV-F and SAdV-G, provisionally
named “simian adenovirus C (SAdV-C)” (Fig. 4 and 5B). Both
BaAdV-2/-4 and BaAdV-3, like members of the SAdV-A and
SAdV-B species, contained the RGD motif in the penton base
protein which mediates binding to v integrins during virus inter-
nalization (29).
Pools of hyperimmune rabbit antisera containing neutralizing
antibodies to the 41 HAdV prototype strains (representing species
A to F) were tested against the BaAdVs. No neutralization was
observed at a starting serum dilution of 1:8 with the exception of
the species F (HAdV-40 and -41) antisera pool that showed low-
level neutralization (1:16) with BaAdV-1 (SAdV-B) and BaAdV-
2/-4 (SAdV-C). Sera from control baboon B107 that was positive
for neutralizing antibody to BaAdV-1 and BaAdV-2/-4 did not
neutralize species G HAdV-52.
Notably, despite sharing 91.2% overall nucleotide identity
across the genome (Fig. 3B), the sequence of BaAdV-3, the only
AdV among the 4 that had been isolated from a symptomatic
baboon, diverged significantly from that of BaAdV-2/-4 in the
short fiber 1 gene. While the other major adenoviral proteins were
90% identical, the short fiber 1 of BaAdV-3 shared only 58%
amino acid identity relative to that of BaAdV-2/-4 (Fig. 5B). Sim-
ilarity and bootscanning plots of BaAdV-3 relative to BaAdV-2/-4
(species SAdV-C) and related AdVs in species SAdV-A, -F, and -G
suggested high likelihood of a recombination event involving the
short fiber 1 gene (Fig. 6). However, if the short fiber 1 gene of
BaAdV-3 is the result of a recombination event, the presumptive
AdV donor strain has yet to be identified, as the BaAdV-3 short
fiber 1 lacked any closely related phylogenetic neighbors (~58% to
BaAdV-2/-4 and 50% amino acid identity to other sequenced
fiber proteins in GenBank).
Seroprevalence of BaAdV-1, BaAdV-3, and BaAdV-2/4 in ba-
boons and humans. Of note, many staff members at the TBRI had
anecdotally reported experiencing “flu-like” symptoms around
the time of onset of the 1997 baboon outbreak. To investigate the
possibility that a cross-species transmission event, either zoonotic
(from baboon to human) or anthroponotic (from human to ba-
boon), may have occurred, preoutbreak and postoutbreak sera
from potentially exposed human staff personnel at the TBRI (Ta-
TABLE 1 Tropism of baboon adenovirus (BaAdV) isolates in human and monkey cells
Cell or cell line
CPEa of virus in cells:
BaAdV-1 BaAdV-2/-4 BaAdV-3
Human
A549 (human epithelial lung adenocarcinoma)   
HFDL (human fetal diploid lung)   
HFDK (human fetal diploid kidney)   
Old World monkey
PMK (primary rhesus monkey kidney)   
Vero (African green monkey kidney)   
CyMK (cynomolgus monkey kidney)   
New World monkey
B95a (marmoset monkey lymphoblastoid)   
a , strong cytopathic effect (CPE); , moderate CPE; , no CPE.
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FIG 2 Genomic coverage of 4 novel baboon adenoviruses (BaAdVs) by deep sequencing. Part of the viral genome was recovered directly from deep sequencing
reads using a de novo assembly approach (black bars). After completion of the genome and confirmation by Sanger sequencing, deep sequencing reads are
mapped to the corresponding AdV genome. The coverage (y axis) achieved at each position along the genome (x axis) is plotted on a logarithmic scale.
Abbreviation: nt, nucleotide.
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FIG 3 Genome organization of BaAdV-1 and BaAdV-2/-4 and pairwise alignment with related adenoviruses. (A and B) Maps of the genome organization
corresponding to two baboon AdVs, BaAdV-1 (A), a species SAdV-B AdV, and BaAdV-2/-4 (B), a novel species SAdV-C AdV, are shown. Boxes above the central
black line represent genes on the forward strand, while boxes below the black line represent genes on the reverse strand. Early region genes are shaded in gray. The
scanning nucleotide pairwise identities of BaAdV-1 (A) and BaAdV-2/-4 (B) relative to selected related human (yellow), simian (brown), or novel baboon (pink)
AdVs are shown ranked in order of decreasing overall percent identity. The x axis refers to the nucleotide position along the genome. Abbreviations: ITR, inverted
terminal repeat; pTP, precursor terminal protein; ORF, open reading frame; DNApol, DNA polymerase; DBP, DNA binding protein; CR1, complement receptor
1; RID-, receptor internalization and degradation.
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FIG 4 Amino acid phylogenetic analysis of BaAdV-1, BaAdV-2/-4, and BaAdV-3 relative to other adenoviruses. (A) Hexon; (B) penton base; (C) DNA
polymerase; (D) fiber. Representative primate AdVs in species A to G, SAdV-A, and SAdV-B, and nonprimate AdVs, were included in the phylogenetic analysis.
Bayesian support levels are displayed at each branching point. The 4 novel BaAdVs identified in this study and the proposed “species SAdV-C” designation are
highlighted in red. Scale bars indicate the number of amino acid substitutions per site. Abbreviations and GenBank accession numbers are given in the text.
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ble 2, human 1 [H1] to H6) were tested for antibodies to BaAdV-1,
BaAdV-3, and BaAdV-2/-4 by virus neutralization in a blinded
fashion. As additional controls for baseline seroprevalence, we
also tested sera from a random selection of 5 young children and
available sera from 10 baboons born approximately the same time
as affected baboons with pneumonia, but not part of the 1997
outbreak. Significantly, 5 of 6 (83%) and 6 of 6 (100%) personnel,
while seronegative prior to the outbreak, had evidence of neutral-
izing antibody titers to BaAdV-1 and BaAdV-2/-4, respectively,
after the outbreak. The highest neutralizing antibody response,
1:160, corresponded to the researcher in closest contact with sick
baboons during the 1997 outbreak (Table 2, H1). Interestingly, no
neutralization to BaAdV-3 was observed in any of the staff per-
sonnel. The specificity of the neutralization assays was further
BaAdV-2/-4  (baboon, species SAdV-C) 
BaAdV-3  (baboon, species SAdV-C) 
SAdV-A1335 (rhesus, species SAdV-B) 
SAdV-3 (rhesus, species SAdV-A) 
SAdV-18 (vervet) 
TMAdV (titi) 
HAdV-12 (human, species A) 
HAdV-14 (human, species B) 
HAdV-1 (human, species C) 
HAdV-8 (human, species D) 
HAdV-4 (human, species E) 
HAdV-40 (human, species F) 
HAdV-52 (human, species G) 
MAdV-2 (mouse) 
BaAdV-1 (baboon, species SAdV-B) 
BaAdV-3 (baboon, species SAdV-C) 
SAdV-A1335 (rhesus, species SAdV-B) 
SAdV-3 (rhesus, species SAdV-A) 
SAdV-18 (vervet) 
HAdV-12 (human, species A) 
HAdV-14 (human, species B) 
HAdV-1 (human, species C) 
HAdV-8 (human, species D) 
HAdV-4 (human, species E) 
HAdV-40 (human, species F) 




Amino Acid Pairwise Identity against BaAdV-1  (species SAdV-B) 
Amino Acid Pairwise Identity against BaAdV-2/-4  (species SAdV-C) 



































































































































































































































































*highest identity between the short fiber1 protein of BaAdV-3 and that of any other AdV
FIG 5 Amino acid pairwise identities of BaAdV-1 and BaAdV-2/-4 relative to other adenoviruses. Comparisons are made against representative human, simian,
and murine AdVs. The amino acid pairwise identity table is displayed as a heat map; colors ranging from blue to white to red correspond to pairwise identities
of 10 to 100% (color bar). The black cells denote AdVs that lack short fibers.
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confirmed by the screening of 5 epidemiologically unassociated
human children under 5 years of age, all of whom were negative
for neutralizing antibodies to BaAdV-1, BaAdV-2/-4, and
BaAdV-3. Among 11 healthy baboons in the colony who were not
part of the 1997 outbreak, 4 of 11 (36%) (from sera collected in
2002–2003) and 3 of 11 (27%) (from sera collected in 1996 and
2003) harbored antibodies to BaAdV-1 and BaAdV-2/-4, respec-
tively (Table 2, B101 to B111). Very little to no neutralization was
observed to BaAdV-3; neutralizing antibody at 1:8 titer was de-
tected in only one baboon, B108, who also had a titer of 1:64 to
closely related strain BaAdV-2/-4.
DISCUSSION
An outbreak of rapidly fatal adenoviral pneumonia in infant baboons
occurred in 1997 at the Primate Research Center of the TBRI. The
diagnosis of primary AdV infection was supported by the presence of
atypical lymphocytes in the peripheral circulation, hemorrhagic and
necrotic lesions in the lung and liver, and intranuclear inclusions in
bronchial epithelium, with subsequent confirmation by direct isola-
tion of AdV from lung tissue. Two of four baboons presenting with
acute respiratory infection (50%) died in the 1997 outbreak. Al-
though the number of deaths is small, the case fatality rate of 50% is
high for AdV infections, which typically cause much lower mortality
rates in susceptible human children of 15% (30–32). One explana-
tion for the high death rate may be the concurrent presence of bacte-
ria such as MSSA in at least one of the 2 baboons, which may have
predisposed AdV-infected baboons to severe and potentially fatal
bacterial superinfections of the lung (33). It is also possible that new-
born baboons are highly susceptible in general to severe infection
from AdVs, which are known to be associated with more severe dis-
ease in humans who are immunocompromised, elderly, or very
young (7, 34).
BaAdV-3 (species SAdV-C)
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FIG 6 Evidence for recombination in species SAdV-C adenovirus BaAdV-3. Similarity (top) and bootscanning (bottom) plots of AdVs in species SAdV-A,
SAdV-B, SAdV-C, -F, and -G relative to BaAdV-3 are shown. Bootscanning analysis reveals likely recombination breakpoints in the region corresponding to the
divergent short fiber 1 gene (asterisk). The x axis refers to the nucleotide position. The genome organization map is annotated in the same fashion as in Fig. 2.
Abbreviation: nt, nucleotide.
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The AdV strains isolated from lung tissue from the two ba-
boons who died from pneumonia were untypeable by virus neu-
tralization testing for AdVs in HAdV species A to F and SAdV-A,
including HAdVs in species B, C, and E that are typically associ-
ated with human respiratory disease and pneumonia (35). This
finding raised the possibility that the causative agent of the out-
break may be a novel AdV strain of unknown pathogenicity. Since
tissue and primary cultures from the two fatal cases had been sent
out to off-site laboratories in 1997 and were unavailable for fur-
ther analysis, we sought to characterize AdVs isolated from other
symptomatic and/or asymptomatic baboons (BaAdVs) involved
in the 1997 outbreak. Four AdV isolates (BaAdV-1 to BaAdV-4)
were successfully cultured from nasal swabs in 1997, of which only
one, BaAdV-3, was derived from a baboon with acute respiratory
symptoms. Similar to the two AdV strains from dead baboons, the
4 isolates were untypeable at the time of the outbreak for HAdV
species A to F and SAdV-A by virus neutralization testing (al-
though subsequent repeat neutralization testing against HAdV
species A to G in 2012 found a low level of serological cross-
reactivity between BaAdV-1 or BaAdV-2/4 and members of spe-
cies HAdV-F).
To further characterize these untypeable AdVs, the genomes
corresponding to all 4 isolates were recovered by a combined deep
sequencing, traditional Sanger sequencing, and de novo assembly
approach (Fig. 2). BaAdV-1 was found to be a member of the
recently described SAdV-B species (18), but BaAdV-2, BaAdV-3,
and BaAdV-4 (identical to BaAdV-2) were found to represent
members of a potentially novel species (Fig. 3B and 4). Both
BaAdV-2/-4 and BaAdV-3 meet one of the main ICTV criteria for
a new AdV species by exhibiting 10% phylogenetic distance
from their nearest AdV neighbors, members of human and ad-
enoviral species F and G (Fig. 3B) (17). The absence of cross-
neutralization with BaAdV-3 and very weak cross-neutralization
with BaAdV-2/-4 and the HAdV-F AdVs also support the conten-
tion that these BaAdVs are novel serotypes. Thus, we propose the
designation “simian adenovirus C (SAdV-C)” for this new species,
in accordance with previously established taxonomic criteria for
adenoviruses and following the identification of the SAdV-A and
SAdV-B species (17, 18, 36–38).
Interestingly, BaAdV-3, despite sharing 91.2% overall nucleo-
tide identity to BaAdV-2/-4 (Fig. 3B), exhibits little to no cross-
reactivity with BaAdV-2/-4 in testing of both human and baboon
sera (Table 2). The basis for this serological specificity may be the
sequence of the short fiber 1, which diverges significantly in
BaAdV-3 relative to both BaAdV-2/-4 and all other sequenced
AdVs (58% identity at the amino acid level) (Fig. 5B). Bootscan
analysis suggests that BaAdV-3 may have arisen from a recombi-
nation event involving a species SAdV-C AdV such as BaAdV-2/-4
and an as-yet unidentified donor strain harboring the divergent
BaAdV-3 short fiber 1 (Fig. 6). Since productive infection by
BaAdV-3, but not BaAdV-2/-4, was observed in two human fetal
cell lines (Table 1), we speculate that this donor strain may poten-
tially be a human adenovirus, or at least human-tropic. A search
for this presumptive AdV donor strain is now under way.
Anecdotal reports of “flu-like” symptoms in staff members
around the time of the 1997 baboon outbreak precipitated an
investigation of serological responses to BaAdV-1, BaAdV-2/-4,
and BaAdV-3 in present-day baboons in the colony and poten-
tially exposed staff personnel at the TBRI. Neutralizing antibody
titers to BaAdV-1 (species SAdV-B) and BaAdV-2/-4 (species
SAdV-C) were detected in both baboons and humans (Table 2).
Although it is possible that these titers may reflect borderline
cross-reactivity with human species F AdVs, we deem it more
likely that BaAdV-1 (species SAdV-B) and BaAdV-2/-4 (species
SAdV-C) are serologically distinct from HAdV-F, given the low
hexon and fiber homology (Fig. 5), and the high rates of serocon-
TABLE 2 Human and baboon serum antibody neutralization titers with baboon adenovirus (BaAdV) isolates
Serum specimena
Date (mo/day/yr) collectedc
Serum antibody neutralization titerc with:
BaAdV-1 BaAdV-2/-4 BaAdV-3
Pre Post Pre Post Pre Post Pre Post
Laboratory staffb
H1 1/20/1993 5/6/1997  1:128  1:128  
H2 8/30/1988 5/6/1997  1:64  1:64  
H3 1/20/1993 5/6/1997  1:64  1:64  
H4 3/16/1993 5/6/1997  1:32  1:32  
H5 1/20/1993 5/6/1997    1:64  
H6 8/30/1988 5/6/1997  1:64  1:64  
Baboon controls
B101 NA 6/9/2003 NA  NA  NA 
B102 6/1/1996 9/4/2002  1:8    
B103 7/1/1996 NA  NA 1:8 NA  NA
B104 8/10/1996 NA  NA  NA  NA
B105 NA 12/31/2001 NA  NA  NA 
B106 NA 7/15/2002 NA  NA  NA 
B107 NA 6/24/2003 NA  NA  NA 
B108 NA 2/21/2003 NA 1:8 NA 1:64 NA 1:8
B109 NA 5/22/2003 NA 1:8 NA 1:8 NA 
B110 NA 5/20/2004 NA  NA  NA 
B111 NA 12/04/2003 NA 1:8 NA  NA 
a Sera from 5 epidemiologically unrelated young children were also tested to serve as negative human controls. All lacked neutralizing antibodies to BaAdV-1, BaAdV-2/-4, and
BaAdV-3 at a 1:8 screening dilution.
b H1 to H6, laboratory staff at the Texas Biomedical Research Institute (TBRI) during the outbreak; B101 to B111, asymptomatic baboons housed at the TBRI from 1996 to 2004.
c Sera were collected before (Pre) and after (Post) the 1997 outbreak. , negative antibody titer at 1:8 screening dilution; NA, not available.
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version and magnitude of antibody titer rise in exposed staff per-
sonnel over a relatively brief 4-year period (Table 2). Thus, our
serological results may provide the first glimpse of zoonotic trans-
mission of presumptive simian AdVs in species SAdV-B and the
novel species SAdV-C to exposed humans. However, as we cannot
rule out the possibility of cross-reactivity to known human AdVs
at this time, broader prevalence studies of seroreactivity to
BaAdVs in the human populations will be needed to confirm these
findings.
Several lines of evidence support the conclusion that BaAdV-3,
a novel species SAdV-C AdV, is the most likely cause of the pneu-
monia outbreak in 1997. First, BaAdV-3, a member of SAdV-C,
was the only sequenced AdV that was isolated from a sick baboon
with acute respiratory symptoms. Second, this SAdV-C-infected
baboon was in a cage situated nearby and in the same room as the
two baboons that died from pneumonia and untypeable AdVs
could be isolated from lung tissue. Third, aside from untypeable
AdVs isolated directly from lung tissue from both fatal cases, the
only other infectious agents isolated were MSSA and Kluyvera
ascorbata in one of the 2 dead baboons. Collectively with the se-
rological testing showing little to no seroreactivity to BaAdV-3 in
asymptomatic control baboons and human staff researchers, these
data suggest that BaAdV-3 may be a rare pathogenic SAdV-C re-
combinant whose emergence precipitated the outbreak. Further
studies, including experimental infections with SAdV-C viruses in
baboons and more extensive assessment of seroprevalence in hu-
man and monkey populations are needed to investigate this pos-
sibility.
MATERIALS AND METHODS
Ethics statement. This study was performed in strict accordance with the
Guide for Care and Use of Laboratory Animals (39). The use and care of all
animals followed policies and guidelines established by the Institutional
Animal Care and Use Committee (IACUC) and the Institutional Biohaz-
ards Committee of the TBRI. The protocol for the maintenance and
breeding of the baboon study was approved by the TBRI IACUC. No
specific animal research protocol was drafted for this study, as only excess
clinical samples were analyzed for diagnostic purposes. Extensive veteri-
nary care was provided to all animals affected by the outbreak to minimize
pain and distress. Written informed consent was obtained from the staff
of the TBRI for analysis of their samples and analyzed under protocols
approved by the University of California, San Francisco (UCSF) institu-
tional review board (IRB). Any potentially identifying information has
been provided with the explicit permission of the individual involved.
Biosafety. Analysis of necropsy tissues and cultivation of the novel
baboon AdVs described in this study were performed under biosafety level
2 (BSL-2) conditions as approved by the Institutional Biohazards Com-
mittees of the TBRI and Centers for Disease Control and Prevention
(CDC). Nucleic acid extractions of AdV cultures were performed at the
University of California, San Francisco in BSL-2 facilities specifically cer-
tified by the UCSF Biosafety Committee for handling novel simian AdVs.
Serological analysis of human and baboon sera was performed in a BSL-2
laboratory at the California Department of Public Health (DPH).
Outbreak management and investigation. The baboon outbreak
lasted approximately 3 weeks from 21 February to mid-March of 1997.
Affected baboons were quarantined immediately after development of
respiratory symptoms. The two baboons with fatal cases died or were
humanely euthanized 5 and 13 days after the onset of clinical signs. Daily
reports on clinical and epidemiological parameters were tracked and re-
corded by veterinary and management staff. In response to the outbreak,
all incubator rooms were decontaminated with paraformaldehyde gas.
Cages, walls, floors, and all exposed work area surfaces were cleaned with
2.6% buffered glutaraldehyde (Metricide) or bleach. Disposable protec-
tive suits and gloves were worn at all times when feeding or otherwise in
contact with infant baboons for a period of at least 2 weeks. Hematological
testing and cultures for bacteria, mycoplasma, and fungi were performed
at the University of Texas Health Science Center at San Antonio (UTH-
SCSA). Samples were also tested for respiratory syncytial virus (RSV),
influenza virus, parainfluenza, human adenovirus, and herpesviruses, in-
cluding cytomegalovirus (CMV), at the UTHSCSA. In cultures manifest-
ing cytopathic effects, the presence of adenovirus was confirmed by im-
munofluorescence microscopy with an anti-hexon antibody conjugate.
Respiratory samples were sent out to an off-site laboratory and tested for
Bordetella pertussis, Chlamydophila spp., Mycoplasma spp., Ureaplasma
spp., Legionella spp., and hantavirus. AdV typing by virus neutralization
testing using sera reactive against HAdV species A to F and SAdV-A vi-
ruses was performed at Viral Reference Laboratories, Inc., in San Antonio,
TX, in 1997. Culturing of baboon AdVs was performed at the UTHSCSA,
CDC, and California DPH.
Pathology. Gross and histopathological analyses of necropsy tissues
were performed by a board-certified veterinary pathologist at the Primate
Research Center of the TBRI. Necropsy tissues were fixed in 10% formalin
and embedded in paraffin. Five-micron-thick sections were then cut using
a microtome, stained with hematoxylin and eosin (H&E), and examined
by light microscopy.
Nucleic acid extraction. Two hundred microliters of sample was first
passed through a 0.4-m-pore-size filter to remove bacteria and cellular
debris and then treated with RNase (Invitrogen, Carlsbad, CA). Total
nucleic acid was then extracted from cultured AdV supernatant using
commercially available kits (Qiagen, Valencia, CA).
Virus cultivation. All inoculations of monkey cells (PMK, or primary
monkey kidney; CyMK, or cynomolgus monkey kidney; and Vero [Afri-
can green monkey kidney]) were made using primary nasal swab speci-
mens. Inoculations of human cells and cell lines were made with P1 virus
after a single passage in monkey cells. The cells or cell lines were grown in
media consisting of Hank’s medium (for A549 cells) or Dulbecco’s mod-
ified Eagle’s medium (DMEM) (for other cells) supplemented with 1
nonessential amino acids (Invitrogen, Carlsbad, CA), 10% fetal bovine
serum (FBS), 100 U of penicillin/ml, and 100 g of streptomycin/ml.
After 80 to 90% confluence was achieved, cell culture media were changed
to maintenance media with 2% FBS and inoculated with 200 l of clinical
sample or 100 l of passaged viral supernatant. Prior to inoculation, nasal
samples were clarified by centrifugation at 4,000  g for 10 min; lung
tissue was homogenized using a tissue homogenizer in 5 volumes of buf-
fer. Prior to passaging, cell culture supernatant was subjected to 3 freeze-
thaw cycles and clarified as described above. Viral replication was moni-
tored over 2 weeks by visual inspection under light microscopy for CPE.
Supernatants of viral cell lysates were quantified using an endpoint dilu-
tion assay.
Deep sequencing library preparation. Deep sequencing libraries
were prepared for whole-genome AdV sequencing using a variation of the
TruSeq protocol (Illumina, San Diego, CA) (3). Briefly, nucleic acid ex-
tracts were randomly amplified to cDNA using a round A/B procedure as
previously described (40, 41), and then digested using the restriction en-
zyme BpmI (New England Biolabs, Ipswich, MA) for 2 h at 37°C, followed
by end repair and A-tailing with Klenow and Taq polymerase, respectively
(Invitrogen, Carlsbad, CA). Size selection targeting 200- to 300-bp frag-
ments was then performed using AMPure beads, followed by attachment
of adapters containing 6-nucleotide barcode tags using DNA ligase. Final
libraries were quantified using the Bioanalyzer DNA 12000 chip (Agilent)
and SYBR Fast quantitative PCR (qPCR) system (KAPA Biosystems),
pooled into a single lane, and sequenced on an Illumina HiSeq 2000 in-
strument (100-bp paired-end sequencing).
De novo viral genome assembly. Raw deep sequencing reads were
initially trimmed by removal of adapters, primers, and low-complexity/
low-quality sequences. De novo assembly of partial AdV genomes was
performed using the PRICE assembler (42). Despite high overall coverage
(Fig. 2), de novo assembly of the entire AdV genome was not achieved
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because of (i) the significant degree of variation in coverage (especially for
BaAdV-1) and (ii) the fact that PRICE is a “seed-based” assembler that
assembles into contiguous regions and not a true de novo assembler. All
gaps were subsequently filled by PCR using specific primers designed from
assembled regions followed by Sanger sequencing. PCR and Sanger se-
quencing were also used to confirm the correctness of the assembly. After
assembly of the full viral genomes corresponding to the 4 BAdV isolates,
trimmed deep sequencing reads were then mapped to the AdV genome
using Geneious software (43) with the following parameters (no gaps
allowed, maximum mismatches allowed per read of 5%, and maximum
ambiguity of 1).
Structural features and phylogenetic analysis. The predicted coding
regions in BaAdV genomes were identified using the fully annotated ge-
nome sequences of species F and G AdVs in GenBank as a reference. First,
each BaAdV genome was aligned to the most similar reference genome in
GenBank, followed by identification of open reading frames (ORFs) using
Geneious. The selection of ORFs required the presence of an ATG start
codon, a 100-amino-acid (aa) minimum size, and a match to a corre-
sponding ORF in an annotated AdV reference genome. The GT-AG in-
tron start-stop signal was used to predict the splice donor and acceptor
sites for spliced genes. To confirm the accuracy of the predicted coding
regions, each identified ORF was then aligned using BLASTx to a reference
database consisting of all adenoviral proteins in GenBank. Whole-
genome nucleotide pairwise identity plots (window size of 100) and
amino acid pairwise identity calculations were performed in Geneious.
Similarity and bootscanning plots were generated using Simplot (44),
with a window size of 1,000 bp and a step size of 50 bp.
To construct the amino acid phylogeny trees corresponding to the
hexon, penton base, DNA polymerase, and short/long fiber proteins, the
translated protein sequences corresponding to representative human and
simian AdVs in species A to G, SAdV-A, and SAdV-B, as well as nonpri-
mate AdVs, were first downloaded from GenBank. Multiple sequence
alignments were then performed using the FFT-NS-i1000 algorithm of
MAFFT at default parameters (45). A phylogenetic tree was constructed in
Geneious using the Jukes-Cantor neighbor-joining method and 5,000
bootstrap replicates and a support threshold percentage of 25, using mu-
rine adenovirus 2 (MAdV-A) as an outgroup.
Baboon adenovirus neutralization assay (human and baboon sera).
Viral stocks of BaAdV-1, BaAdV-2, and BaAdV-3 were generated by pas-
saging in Vero E6 cells, aliquoted, and quantitated by endpoint dilution.
To perform the virus neutralization assay, 100 l of viral supernatant
mixed with serum or control serum was incubated for 1 h at 37°C. After
incubation, the mixture was inoculated into wells containing 4,000 Vero
E6 cells per well and incubated at 37°C and 5% CO2. The cells in the wells
on the plate were observed every other day for evidence of CPE. For cells
in wells that showed inhibition of viral CPE at the screening dilution of
1:10, the corresponding serum samples were diluted 2-fold from 1:8 to
1:128 and then retested. The reciprocal of the highest dilution where rep-
licate well monolayers showed no CPE was taken as the neutralizing an-
tibody titer.
Human adenovirus A to F cross-neutralization assay (rabbit typing
sera). Five pools of rabbit hyperimmune reference sera at the California
DPH, collectively containing antibodies to human AdV species A to E,
were available for testing. An individual rabbit serum sample reactive to
HAdV-40 and HAdV-41 was also available for cross-neutralization testing
of HAdV-F. For each pool, rabbit sera at a screening dilution of 1:8 and
100 l of viral supernatant at a 50% tissue culture infective dose (TCID50)
of 103/ml were mixed and inoculated into Vero E6 cells. Cells in wells on
the plate were observed every other day for 2 weeks for evidence of CPE.
For cells in wells that showed inhibition of viral CPE at the screening
dilution of 1:8, the corresponding serum samples were diluted 2-fold from
1:8 to 1:128 and then retested.
Human adenovirus G indirect cross-neutralization assay (baboon
sera). Since neutralizing reference sera to human HAdV-52 (species G)
was not available, the serum sample from baboon B108, shown previously
to be positive for neutralizing antibody to species SAdV-B and SAdV-C
AdVs (Table 2), was tested for cross-neutralization of HAdV-52 in an
indirect neutralization assay. To perform the assay, 100 l HAdV-52 su-
pernatant at a TCID50 of 103/ml was mixed with serum from baboon B108
at the screening dilution of 1:8 and used to inoculate Vero E6 cells. The
cells in wells were observed every other day for 2 weeks for evidence of
CPE.
Nucleotide sequence accession numbers. GenBank accession num-
bers for the adenoviral sequences used in Fig. 3 to 5 are as follows: CAdV-1
(canine adenovirus 1), AC_000003; HAdV-1, AC_000017; HAdV-3,
DQ086466; HAdV-4, AY458656; HAdV-7, AC_000018; HAdV-8,
AF532578; HAdV-12, NC_001460; HAdV-14, FJ822614; HAdV-18,
GU191019; HAdV-21, AY601633; HADV-36, GQ384080; HAdV-40,
NC_001454; HAdV-41, DQ315364; HAdV-48, EF153473; HAdV-49,
DQ393829; HAdV-50, AY737798; HAdV-52, DQ923122; MAdV-2 (mu-
rine adenovirus 2), NC_014899; PAdV-3 (porcine adenovirus A),
AC_000009; SAdV-1, AY771780; SAdV-3, NC_006144; SAdV-6,
JQ776547; SAdV-7, DQ792570; SAdV-18, FJ025931; SAdV-20,
HQ605912; SAdV-21, AC_000010; SAdV-22, AY530876; SAdV-48,
HQ241818; SAdV-49, NC_015225; SAdV-50, HQ241820; SAdV-A1139,
JN880448; SAdV-A1163, JN880449; SAdV-A1173, JN880450; SAdV-
A1258, JN880451; SAdV-A1312, JN880454; SAdV-A1335, JN880456;
TMAdV (titi monkey adenovirus), HQ913600; TSAdV (tree shrew ade-
novirus), NC_004453. The complete genome sequences of BaAdV-1,
BaAdV-2, BaAdV-3, and BaAdV-4 (genetically identical to BaAdV-2)
have been submitted to GenBank (accession numbers KC693021 to
KC693024). Deep sequencing reads have been submitted to the NCBI
Sequence Read Archive (accession number SRA067619).
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